NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,487,525 | -2.7% | 73,508 | -3.6% | 0.09% | +10.6% |
Q2 2023 | $7,693,681 | +9.7% | 76,243 | -0.0% | 0.08% | -5.6% |
Q1 2023 | $7,015,920 | +7.1% | 76,260 | +5.7% | 0.09% | -4.3% |
Q4 2022 | $6,548,260 | +19.4% | 72,181 | +0.0% | 0.09% | +17.5% |
Q3 2022 | $5,485,000 | -9.9% | 72,159 | +0.2% | 0.08% | 0.0% |
Q2 2022 | $6,089,000 | -4.7% | 72,039 | -1.1% | 0.08% | +31.1% |
Q1 2022 | $6,391,000 | +0.3% | 72,830 | -0.1% | 0.06% | +17.3% |
Q4 2021 | $6,374,000 | +6.9% | 72,868 | -0.0% | 0.05% | +246.7% |
Q3 2021 | $5,960,000 | -10.6% | 72,873 | -0.2% | 0.02% | -74.1% |
Q2 2021 | $6,664,000 | -5.8% | 73,049 | -11.7% | 0.06% | -14.7% |
Q1 2021 | $7,071,000 | -9.8% | 82,719 | -0.3% | 0.07% | 0.0% |
Q4 2020 | $7,835,000 | -11.6% | 82,980 | -18.6% | 0.07% | -29.9% |
Q3 2020 | $8,862,000 | -0.2% | 101,902 | +0.2% | 0.10% | -6.7% |
Q2 2020 | $8,884,000 | -1.0% | 101,717 | -6.5% | 0.10% | -16.1% |
Q1 2020 | $8,972,000 | -12.9% | 108,821 | +0.1% | 0.12% | +8.8% |
Q4 2019 | $10,297,000 | +12.7% | 108,745 | +3.5% | 0.11% | +9.6% |
Q3 2019 | $9,134,000 | -4.6% | 105,114 | +0.2% | 0.10% | +2.0% |
Q2 2019 | $9,574,000 | -41.9% | 104,860 | -38.8% | 0.10% | -35.4% |
Q1 2019 | $16,474,000 | -7.6% | 171,353 | -17.5% | 0.16% | -14.1% |
Q4 2018 | $17,821,000 | -0.9% | 207,689 | -0.5% | 0.18% | +25.2% |
Q3 2018 | $17,986,000 | +49.4% | 208,744 | +31.0% | 0.15% | +50.0% |
Q2 2018 | $12,037,000 | +15.7% | 159,356 | +23.8% | 0.10% | +15.3% |
Q1 2018 | $10,408,000 | +7.9% | 128,731 | +12.0% | 0.08% | +9.0% |
Q4 2017 | $9,648,000 | +165.5% | 114,912 | +171.5% | 0.08% | +169.0% |
Q3 2017 | $3,634,000 | -3.4% | 42,326 | -6.1% | 0.03% | -6.5% |
Q2 2017 | $3,763,000 | +117.1% | 45,081 | +93.2% | 0.03% | +121.4% |
Q1 2017 | $1,733,000 | +1.9% | 23,336 | 0.0% | 0.01% | +7.7% |
Q4 2016 | $1,700,000 | -7.3% | 23,336 | +0.5% | 0.01% | -7.1% |
Q3 2016 | $1,833,000 | +6.9% | 23,213 | +11.7% | 0.01% | +7.7% |
Q2 2016 | $1,714,000 | +13.9% | 20,776 | 0.0% | 0.01% | +18.2% |
Q1 2016 | $1,505,000 | -21.0% | 20,776 | -6.2% | 0.01% | -21.4% |
Q4 2015 | $1,906,000 | -9.5% | 22,151 | -3.4% | 0.01% | -6.7% |
Q3 2015 | $2,107,000 | -29.2% | 22,926 | -24.3% | 0.02% | -21.1% |
Q2 2015 | $2,978,000 | -0.3% | 30,276 | 0.0% | 0.02% | +35.7% |
Q1 2015 | $2,986,000 | +46.1% | 30,276 | +37.2% | 0.01% | +55.6% |
Q4 2014 | $2,044,000 | -51.5% | 22,064 | -50.7% | 0.01% | -47.1% |
Q3 2014 | $4,214,000 | +4.0% | 44,774 | 0.0% | 0.02% | 0.0% |
Q2 2014 | $4,053,000 | +39.0% | 44,774 | +30.6% | 0.02% | +41.7% |
Q1 2014 | $2,915,000 | -24.6% | 34,294 | -28.7% | 0.01% | -25.0% |
Q4 2013 | $3,864,000 | +24.3% | 48,069 | +18.6% | 0.02% | +14.3% |
Q3 2013 | $3,109,000 | -45.7% | 40,524 | -50.0% | 0.01% | 0.0% |
Q2 2013 | $5,730,000 | – | 81,048 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
Elefante Mark B | 4,579 | $333,000 | 4.02% |
COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |